Literature DB >> 30297337

Macular spatial distribution of preserved autofluorescence in patients with choroideremia.

Amir H Hariri1,2, Michael S Ip1,2, Aniz Girach3, Byron L Lam4, M Dominik Fischer5, Eeva-Marja Sankila6, Mark Edward Pennesi7, Frank G Holz8, Robert E Maclaren9,10, David G Birch11, Carel B Hoyng12, Ian M MacDonald13, Graeme C Black14, Stephen H Tsang15,16, Neil M Bressler17, Kimberly E Stepien18, Michael Larsen19, Michael B Gorin2, Isabelle Meunier20, Andrew R Webster21,22, SriniVas Sadda23,2.   

Abstract

BACKGROUND/AIMS: To better understand the pattern of degeneration progression in cases with choroideremia.
METHODS: A cohort of genotypically confirmed choroideremia cases who underwent optical coherence tomography (OCT) and fundus autofluorescence (FAF) imaging was studied. Using HEYEX review software, the foveal centre was marked on FAF images under guidance of corresponding OCT images, followed by application of an ETDRS grid. The boundaries of preserved autofluorescence (AF) were manually segmented in each individual ETDRS subfield. The regional distribution of preserved AF was assessed by comparing its area among the various subfields.
RESULTS: A total of 168 eyes from 84 choroideremia cases were enrolled. There was a statistically significant difference in the amount of preserved AF area between inner subfields as determined by one-way analysis of variance (F (3,668)=9.997, p<0.001) and also between outer subfields (F (3,668)=8.348, p<0.001). A Tukey posthoc test revealed that the preserved AF area in the nasal subfields in both the inner and outer subfields was significantly smaller compared with analogue subfields.
CONCLUSION: The asymmetric spatial distribution of preserved AF in choroideremia (corresponding to the stellate shaped nature of these regions) suggests that the progression of degeneration has directional preference. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  choroideremia; ellipsoid zone; fundus autofluorescence; optical coherence tomography; preserved autofluorescence; retinal pigment epithelium

Mesh:

Year:  2018        PMID: 30297337      PMCID: PMC6533159          DOI: 10.1136/bjophthalmol-2018-312620

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  Normative data of outer photoreceptor layer thickness obtained by software image enhancing based on Stratus optical coherence tomography images.

Authors:  U C Christensen; K Kroyer; J Thomadsen; T M Jorgensen; M la Cour; B Sander
Journal:  Br J Ophthalmol       Date:  2008-06       Impact factor: 4.638

2.  Spatial distribution of posterior pole choroidal thickness by spectral domain optical coherence tomography.

Authors:  Yanling Ouyang; Florian M Heussen; Nils Mokwa; Alexander C Walsh; Mary K Durbin; Pearse A Keane; P James Sanchez; Humberto Ruiz-Garcia; Srinivas R Sadda
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

3.  Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Alexander Sumaroka; Tomas S Aleman; Sharon B Schwartz; Elizabeth A M Windsor; Alejandro J Roman; Edwin M Stone; Ian M MacDonald
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

4.  A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement.

Authors:  Sara J Bowne; Marian M Humphries; Lori S Sullivan; Paul F Kenna; Lawrence C S Tam; Anna S Kiang; Matthew Campbell; George M Weinstock; Daniel C Koboldt; Li Ding; Robert S Fulton; Erica J Sodergren; Denis Allman; Sophia Millington-Ward; Arpad Palfi; Alex McKee; Susan H Blanton; Susan Slifer; Ioanna Konidari; G Jane Farrar; Stephen P Daiger; Peter Humphries
Journal:  Eur J Hum Genet       Date:  2011-06-08       Impact factor: 4.246

5.  Cloning of a gene that is rearranged in patients with choroideraemia.

Authors:  F P Cremers; D J van de Pol; L P van Kerkhoff; B Wieringa; H H Ropers
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

6.  Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa.

Authors:  David G Birch; Kirsten G Locke; Yuquan Wen; Kelly I Locke; Dennis R Hoffman; Donald C Hood
Journal:  JAMA Ophthalmol       Date:  2013-09       Impact factor: 7.389

7.  Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase.

Authors:  M C Seabra; M S Brown; J L Goldstein
Journal:  Science       Date:  1993-01-15       Impact factor: 47.728

8.  Measurement and Reproducibility of Preserved Ellipsoid Zone Area and Preserved Retinal Pigment Epithelium Area in Eyes With Choroideremia.

Authors:  Amir H Hariri; Swetha B Velaga; Aniz Girach; Michael S Ip; Phuc V Le; Byron L Lam; M Dominik Fischer; Eeva-Marja Sankila; Mark E Pennesi; Frank G Holz; Robert E MacLaren; David G Birch; Carel B Hoyng; Ian M MacDonald; Graeme C Black; Stephen H Tsang; Neil M Bressler; Michael Larsen; Michael B Gorin; Andrew R Webster; SriniVas R Sadda
Journal:  Am J Ophthalmol       Date:  2017-05-10       Impact factor: 5.258

9.  Characterizing the Natural History of Visual Function in Choroideremia Using Microperimetry and Multimodal Retinal Imaging.

Authors:  Jasleen K Jolly; Kanmin Xue; Thomas L Edwards; Markus Groppe; Robert E MacLaren
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

10.  Visual Acuity after Retinal Gene Therapy for Choroideremia.

Authors:  Thomas L Edwards; Jasleen K Jolly; Markus Groppe; Alun R Barnard; Charles L Cottriall; Tanya Tolmachova; Graeme C Black; Andrew R Webster; Andrew J Lotery; Graham E Holder; Kanmin Xue; Susan M Downes; Matthew P Simunovic; Miguel C Seabra; Robert E MacLaren
Journal:  N Engl J Med       Date:  2016-04-27       Impact factor: 91.245

View more
  8 in total

Review 1.  Gene therapy for inherited retinal diseases.

Authors:  Yan Nuzbrokh; Sara D Ragi; Stephen H Tsang
Journal:  Ann Transl Med       Date:  2021-08

2.  Progress in the development of novel therapies for choroideremia.

Authors:  Jasmina Cehajic Kapetanovic; Maria I Patrício; Robert E MacLaren
Journal:  Expert Rev Ophthalmol       Date:  2019-12-26

3.  Multimodal imaging in a case of choroideremia.

Authors:  Sugandha Goel; Kumar Saurabh; Rupak Roy
Journal:  Indian J Ophthalmol       Date:  2019-09       Impact factor: 1.848

4.  Bilateral visual acuity decline in males with choroideremia: a pooled, cross-sectional meta-analysis.

Authors:  Duygu Bozkaya; Heng Zou; Cindy Lu; Nicole W Tsao; Byron L Lam
Journal:  BMC Ophthalmol       Date:  2022-01-16       Impact factor: 2.209

5.  Synonymous Variant in the CHM Gene Causes Aberrant Splicing in Choroideremia.

Authors:  Mariana Matioli da Palma; Fabiana Louise Motta; Caio Perez Gomes; Mariana Vallim Salles; João Bosco Pesquero; Juliana Maria Ferraz Sallum
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

6.  Quantification of RPE Changes in Choroideremia Using a Photoshop-Based Method.

Authors:  Yi Zhai; Manlong Xu; Ioannis S Dimopoulos; David G Birch; Paul S Bernstein; Jenny Holt; David Kirn; Peter Francis; Ian M MacDonald
Journal:  Transl Vis Sci Technol       Date:  2020-06-18       Impact factor: 3.283

Review 7.  Molecular Therapies for Choroideremia.

Authors:  Jasmina Cehajic Kapetanovic; Alun R Barnard; Robert E MacLaren
Journal:  Genes (Basel)       Date:  2019-09-23       Impact factor: 4.096

Review 8.  Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations.

Authors:  Mays Talib; Camiel J F Boon
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 May-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.